Private company

Axcella Health (United States)

Logo: axcellahealth.com³

American biological products company based in Cambridge, founded in 2008.¹

Last updated Oct 18, 2026.

Overview

2008Founded¹

IndustryBiological Products, (No Diagnostic Substances)¹
HeadquartersCambridge¹
Websitewww.axcellahealth.com
Incorporated inDE⁴
Business address840 Memorial Drive, Third Floor, Cambridge, Ma 02139⁴
Filer category, Emerging growth company⁴

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income⁵⁶⁷⁸-$77.0M in 2022+127% since 2018

Net income⁵⁶⁷⁸-$81.2M in 2022+38% since 2017

Fiscal year	2017	2018	2019	2020	2021	2022
Research and development		$25.5M⁵	$41.7M⁶	$37.0M⁷	$43.1M⁸	$57.0M⁸
Operating income		-$33.9M⁵	-$57.4M⁶	-$53.8M⁷	-$61.8M⁸	-$77.0M⁸
Interest		$2.8M⁵	$3.4M⁵		$2.9M⁸	$3.0M⁸
Net income	-$59.0M⁵	-$36.1M⁵	-$59.0M⁶	-$56.5M⁷	-$64.6M⁸	-$81.2M⁸
Earnings per share				-$1.78⁷	-$1.70⁸	-$1.49⁸
Earnings per share (diluted)				-$1.78⁷	-$1.70⁸	-$1.49⁸

Total assets⁵⁶⁷⁸$18.9M in 2022−77% since 2018

Total liabilities⁵⁶⁷⁸$14.8M in 2022−56% since 2018

Shareholders’ equity⁵⁶⁷⁸$4.2M in 2022

Cash⁵⁶⁷⁸$17.1M in 2022−63% since 2017

Long-term debt⁵⁶⁷⁸$0 in 2022

Fiscal year	2017	2018	2019	2020	2021	2022	2023
Cash	$46.8M⁵	$79.5M⁶	$92.1M⁶	$71.6M⁷	$23.6M⁸	$17.1M⁸
Current assets		$80.3M⁵	$93.5M⁶	$109.0M⁷	$56.6M⁸	$18.0M⁸
Total assets		$81.8M⁵	$94.4M⁶	$109.6M⁷	$57.7M⁸	$18.9M⁸
Current liabilities		$6.9M⁵	$8.4M⁶	$7.8M⁷	$10.2M⁸	$14.1M⁸
Long-term debt		$24.5M⁵	$24.9M⁶	$25.2M⁷	$25.1M⁸	$0⁸
Total liabilities		$33.8M⁵	$34.1M⁶	$34.2M⁷	$35.7M⁸	$14.8M⁸
Shareholders’ equity	-$116.4M⁵	-$149.8M⁶	$60.2M⁷	$75.4M⁸	$22.0M⁸	$4.2M⁸
Shares outstanding		4.8M shares⁵	23.2M shares⁶	37.6M shares⁷	39.2M shares⁸	73.7M shares⁸	73.7M shares⁸

Cash from operations⁵⁶⁷⁸-$69.6M in 2022+127% since 2018

Capital spending⁵⁶⁷⁸$426.0K in 2022−35% since 2018

Free cash flow⁵⁶⁷⁸-$70.0M in 2022+123% since 2018

Fiscal year	2018	2019	2020	2021	2022
Cash from operations	-$30.7M⁵	-$51.0M⁶	-$49.8M⁷	-$54.2M⁸	-$69.6M⁸
Capital spending	$659.0K⁵	$136.0K⁶	$239.0K⁷	$275.0K⁸	$426.0K⁸
Free cash flow	-$31.4M	-$51.1M	-$50.0M	-$54.5M	-$70.0M

Compare Axcella Health (United States) with another company

Leadership

Who has led Axcella Health (United States), and when. Pick a name to see everywhere that person has worked.

Chief executive

William Hinshaw2019–2023

President

Chief financial officer

2010201520202025

Chief executive officerWilliam Hinshaw May 8, 2019 to Feb 24, 2023¹¹
PresidentAlison D. Schecter Mar 18, 2021 to Feb 10, 2022¹²
PresidentWilliam Hinshaw May 8, 2019 to Feb 24, 2023¹¹
Chief financial officerRobert Crane Feb 28, 2022 to Mar 18, 2022¹³
Chief financial officerThomas Leggett May 8, 2019 to May 8, 2019¹⁴
Chief financial officerLaurent Chardonnet Nov 25, 2019 to Feb 11, 2021¹⁵

Board members and other officers (25)

SVP, Chief People OfficerVirginia R. Dean Jun 25, 2021 to Feb 10, 2022¹⁶
Chief Medical OfficerMargaret Koziel Dec 13, 2021 to Mar 3, 2023¹⁷
Chief medical officerManu V Chakravarthy May 8, 2019 to now¹⁸
Senior Vice President, CIPOPaul Fehlner May 8, 2019 to Dec 20, 2019¹⁹
Sr VP, Chief Business OfficerStephen Mitchener May 8, 2019 to Dec 20, 2019²⁰
Sr VP of R&D, CSOTony Tramontin May 8, 2019 to Dec 20, 2019²¹
EVP &Chief Development OfficerShreeram Aradhye May 31, 2019 to Dec 20, 2019²²
OfficerShane Maltbie Aug 29, 2019 to Aug 29, 2019²³
Board memberMartin Hendrix May 23, 2022 to May 23, 2022²⁴
Board memberMichael Rosenblatt May 23, 2022 to May 23, 2022²⁵
Board memberPaul J. Sekhri May 25, 2022 to May 25, 2022²⁶
Board memberRobert L. Rosiello Oct 17, 2022 to Nov 18, 2022²⁷
Board memberTorben Straight Nissen Oct 17, 2022 to Nov 18, 2022²⁸
Board memberShreeram Aradhye Sep 3, 2020 to May 24, 2021²⁹
Board memberChristopher Viehbacher May 8, 2019 to May 8, 2019³⁰
Board memberCristina Rondinone May 8, 2019 to May 23, 2022³¹
Board memberDavid R. Epstein May 8, 2019 to Jun 3, 2022³²
Board memberGary P. Pisano May 8, 2019 to May 23, 2022³³
Board memberGregory Behar May 8, 2019 to May 24, 2021³⁴
Board memberStephen Hoge May 8, 2019 to May 24, 2021³⁵
Board memberWilliam D. Baird Iii. May 8, 2019 to May 23, 2022³⁶
Board memberWilliam Hinshaw May 8, 2019 to Feb 24, 2023¹¹
Board memberCatherine A. Sohn Aug 23, 2019 to May 23, 2022³⁷
General counselPaul Fehlner Sep 18, 2020 to Feb 24, 2023³⁸
General counselHeidy King-Jones Nov 25, 2019 to Dec 20, 2019³⁹

Former names

Pronutria Biosciences, Inc.Feb 17, 2015 to Feb 24, 2016⁴

Timeline

May 8, 2019New chief executive William Hinshaw becomes CEO¹¹
2008Founded Founded¹

Recent filings

Dec 22, 20238-K
Dec 19, 20238-K
Dec 4, 20238-K
Nov 17, 2023DEF 14A
Nov 17, 20238-K
Nov 9, 20238-K
Nov 1, 20238-K
Oct 6, 20238-K
Sep 18, 20238-K
Sep 14, 20238-K
Sep 11, 20238-K
Aug 29, 20238-K
Aug 18, 2023DEF 14A
Aug 4, 20238-K
Aug 3, 20238-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataAxcella Health (United States) on Wikidata
2
SEC EDGARAxcella Health (United States) filings on SEC EDGAR
3
Company websiteAxcella Health (United States) logo
4
SEC EDGARAxcella Health (United States) filings on SEC EDGAR
5
SEC EDGARAxcella Health (United States) 10-K for fiscal 2018
6
SEC EDGARAxcella Health (United States) 10-K for fiscal 2019
7
SEC EDGARAxcella Health (United States) 10-K for fiscal 2020
8
SEC EDGARAxcella Health (United States) 10-K for fiscal 2021
9
SEC EDGARAxcella Health (United States) 10-Q for fiscal 2023
10
SEC EDGARAxcella Health (United States) 10-Q for fiscal 2023
11
SEC EDGARWilliam Hinshaw, Chief executive officer
12
SEC EDGARAlison D. Schecter, President
13
SEC EDGARRobert Crane, Chief financial officer
14
SEC EDGARThomas Leggett, Chief financial officer
15
SEC EDGARLaurent Chardonnet, Chief financial officer
16
SEC EDGARVirginia R. Dean, SVP, Chief People Officer
17
SEC EDGARMargaret Koziel, Chief Medical Officer
18
Wikidata and SEC EDGARManu V Chakravarthy, Chief medical officer
19
SEC EDGARPaul Fehlner, Senior Vice President, CIPO
20
SEC EDGARStephen Mitchener, Sr VP, Chief Business Officer
21
SEC EDGARTony Tramontin, Sr VP of R&D, CSO
22
SEC EDGARShreeram Aradhye, EVP &Chief Development Officer
23
SEC EDGARShane Maltbie, Officer
24
SEC EDGARMartin Hendrix, Board member
25
SEC EDGARMichael Rosenblatt, Board member
26
SEC EDGARPaul J. Sekhri, Board member
27
SEC EDGARRobert L. Rosiello, Board member
28
SEC EDGARTorben Straight Nissen, Board member
29
SEC EDGARShreeram Aradhye, Board member
30
SEC EDGARChristopher Viehbacher, Board member
31
SEC EDGARCristina Rondinone, Board member
32
SEC EDGARDavid R. Epstein, Board member
33
SEC EDGARGary P. Pisano, Board member
34
SEC EDGARGregory Behar, Board member
35
SEC EDGARStephen Hoge, Board member
36
SEC EDGARWilliam D. Baird Iii., Board member
37
SEC EDGARCatherine A. Sohn, Board member
38
SEC EDGARPaul Fehlner, General counsel
39
SEC EDGARHeidy King-Jones, General counsel